East Quogue, NY -- (ReleaseWire) -- 01/08/2015 --Internet Services Group, through its financial investment sites Investor Spec Sheet and TheStockAdvisor, is adding Cell MedX Corp. (OTCBB: CMXC) to its list of featured companies. Investor Spec Sheet and TheStockAdvisor are part of Financial Market Advisor, an industry leader for news and information on unique investment opportunities
Cell MedX Corp. is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. Through its wholly owned subsidiary, Avyonce Cosmedics Inc., Cell MedX Corp. is also engaged in the resale and marketing of spa technology and equipment.
To learn more about Cell MedX Corp. visit http://www.investorspecsheet.com/alerts/010815CMXC.html
About The Internet Services Group
Internet Services Group, through Financial Market Advisor's sites Investor Spec Sheet (http://www.investorspecsheet.com) and TheStockAdvisor (http://www.thestockadvisor.com), provides in-depth profiles and stock alerts for select companies, targeting the speculative investor. Internet Services Group has been providing internet marketing solutions since 2001.
To learn more about Financial Market Advisor, visit http://www.financialmarketadvisor.com. Email: firstname.lastname@example.org
To learn more about Internet Services Group, visit http://www.internetservicesgroup.net
Internet Services Group
472 Montauk Highway
East Quogue, NY 11942
The information provided may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often include words such as "anticipates," "estimates," "expects," "projects," "intends," "plans," "believes" and words and terms of similar substance in connection with discussions of future operating or financial performance.
No information contained on Investor Spec Sheet or in its publications should be considered as a solicitation to purchase or sell the securities of the profiled companies. The information contained on Investor Spec Sheet and in its publications may pertain to small/micro cap and/or thinly traded securities which by their very nature involve an extremely high degree of risk. An investment in these types of securities could result in the loss of some or all of an investment in the company. In addition, due to the illiquid nature of some of these securities, an investor may find encounter difficulties in liquidating the securities.